"sample_molecule_ch1","sample_molecule_ch2","sample_source_name_ch1","sample_status","sample_library_selection","sample_library_source","sample_extract_protocol_ch1","sample_extract_protocol_ch2","sample_label_protocol_ch1","sample_source_name_ch2","sample_library_strategy","sample_characteristics_ch2","sample_label_protocol_ch2","sample_label_protocol","sample_series_id","sample_data_processing","sample_description","sample_characteristics_ch1","sample_organism_ch1","tissue","sample_type","sample_title","sample_name","sample_hyb_protocol","sample_label_ch2","disease_state","ethnicity","time_point","tmprss2","treatment","cancer_status","tissuer_type","tumor_type","age","gleason_score","pathologic_tumor_stage","gleason_grade","t-stage","margin_status","preop_psa","bcr","bcr_free_time"
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 10(time to 1st recurrence (days): 617(time to 1st recurrence (months): 20(time to b-met (days): 1088(follow-up time (days): 1094(follow-up time (months): 35","Homo sapiens",NA,"RNA","Primary Melanoma_001","primary_melanoma_001",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,81,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.7(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 3860(follow-up time (months): 126","Homo sapiens",NA,"RNA","Primary Melanoma_002","primary_melanoma_002",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,65,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.6(time to 1st recurrence (days): 234(time to 1st recurrence (months): 8(time to b-met (days): NA(follow-up time (days): 525(follow-up time (months): 17","Homo sapiens",NA,"RNA","Primary Melanoma_003","primary_melanoma_003",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,87,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.06(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 3092(follow-up time (months): 101","Homo sapiens",NA,"RNA","Primary Melanoma_004","primary_melanoma_004",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,35,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 10.75(time to 1st recurrence (days): 258(time to 1st recurrence (months): 9(time to b-met (days): NA(follow-up time (days): 896(follow-up time (months): 29","Homo sapiens",NA,"RNA","Primary Melanoma_005","primary_melanoma_005",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,76,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 30(time to 1st recurrence (days): 1093(time to 1st recurrence (months): 36(time to b-met (days): NA(follow-up time (days): 1356(follow-up time (months): 44","Homo sapiens",NA,"RNA","Primary Melanoma_006","primary_melanoma_006",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,77,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.6(time to 1st recurrence (days): 1011(time to 1st recurrence (months): 33(time to b-met (days): 1011(follow-up time (days): 1030(follow-up time (months): 33","Homo sapiens",NA,"RNA","Primary Melanoma_007","primary_melanoma_007",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,73,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 5.1(time to 1st recurrence (days): 385(time to 1st recurrence (months): 13(time to b-met (days): NA(follow-up time (days): 601(follow-up time (months): 19","Homo sapiens",NA,"RNA","Primary Melanoma_008","primary_melanoma_008",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,72,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.2(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 3793(follow-up time (months): 124","Homo sapiens",NA,"RNA","Primary Melanoma_009","primary_melanoma_009",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,61,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 10(time to 1st recurrence (days): 573(time to 1st recurrence (months): 18(time to b-met (days): 1734(follow-up time (days): 1953(follow-up time (months): 64","Homo sapiens",NA,"RNA","Primary Melanoma_010","primary_melanoma_010",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,57,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 12(time to 1st recurrence (days): 642(time to 1st recurrence (months): 21(time to b-met (days): NA(follow-up time (days): 1105(follow-up time (months): 36","Homo sapiens",NA,"RNA","Primary Melanoma_011","primary_melanoma_011",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,66,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.1(time to 1st recurrence (days): 2143(time to 1st recurrence (months): 71(time to b-met (days): NA(follow-up time (days): 2284(follow-up time (months): 75","Homo sapiens",NA,"RNA","Primary Melanoma_012","primary_melanoma_012",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,70,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.62(time to 1st recurrence (days): 316(time to 1st recurrence (months): 10(time to b-met (days): NA(follow-up time (days): 1096(follow-up time (months): 36","Homo sapiens",NA,"RNA","Primary Melanoma_013","primary_melanoma_013",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,51,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 10(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 378(follow-up time (months): 12","Homo sapiens",NA,"RNA","Primary Melanoma_014","primary_melanoma_014",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,83,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 5(time to 1st recurrence (days): 830(time to 1st recurrence (months): 27(time to b-met (days): 1085(follow-up time (days): 1196(follow-up time (months): 39","Homo sapiens",NA,"RNA","Primary Melanoma_015","primary_melanoma_015",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,77,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.65(time to 1st recurrence (days): 167(time to 1st recurrence (months): 6(time to b-met (days): 403(follow-up time (days): 471(follow-up time (months): 15","Homo sapiens",NA,"RNA","Primary Melanoma_016","primary_melanoma_016",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,81,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.3(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 3202(follow-up time (months): 105","Homo sapiens",NA,"RNA","Primary Melanoma_017","primary_melanoma_017",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,80,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.85(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1453(follow-up time (months): 47","Homo sapiens",NA,"RNA","Primary Melanoma_018","primary_melanoma_018",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,71,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 0.72(time to 1st recurrence (days): 3497(time to 1st recurrence (months): 115(time to b-met (days): 3703(follow-up time (days): 3735(follow-up time (months): 122","Homo sapiens",NA,"RNA","Primary Melanoma_019","primary_melanoma_019",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,43,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 6(time to 1st recurrence (days): 1463(time to 1st recurrence (months): 48(time to b-met (days): NA(follow-up time (days): 5119(follow-up time (months): 168","Homo sapiens",NA,"RNA","Primary Melanoma_020","primary_melanoma_020",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,74,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 24(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 3185(follow-up time (months): 104","Homo sapiens",NA,"RNA","Primary Melanoma_021","primary_melanoma_021",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,54,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 13(time to 1st recurrence (days): 928(time to 1st recurrence (months): 30(time to b-met (days): NA(follow-up time (days): 3763(follow-up time (months): 123","Homo sapiens",NA,"RNA","Primary Melanoma_022","primary_melanoma_022",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,76,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 5.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2513(follow-up time (months): 82","Homo sapiens",NA,"RNA","Primary Melanoma_023","primary_melanoma_023",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,53,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.9(time to 1st recurrence (days): 1999(time to 1st recurrence (months): 66(time to b-met (days): NA(follow-up time (days): 5081(follow-up time (months): 166","Homo sapiens",NA,"RNA","Primary Melanoma_024","primary_melanoma_024",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,55,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 6(time to 1st recurrence (days): 201(time to 1st recurrence (months): 7(time to b-met (days): NA(follow-up time (days): 440(follow-up time (months): 14","Homo sapiens",NA,"RNA","Primary Melanoma_025","primary_melanoma_025",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,91,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.4(time to 1st recurrence (days): 532(time to 1st recurrence (months): 18(time to b-met (days): NA(follow-up time (days): 665(follow-up time (months): 21","Homo sapiens",NA,"RNA","Primary Melanoma_026","primary_melanoma_026",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,62,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.9(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2801(follow-up time (months): 92","Homo sapiens",NA,"RNA","Primary Melanoma_027","primary_melanoma_027",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,75,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 8(time to 1st recurrence (days): 56(time to 1st recurrence (months): 2(time to b-met (days): 228(follow-up time (days): 267(follow-up time (months): 8","Homo sapiens",NA,"RNA","Primary Melanoma_028","primary_melanoma_028",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,42,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 11.5(time to 1st recurrence (days): 220(time to 1st recurrence (months): 7(time to b-met (days): 220(follow-up time (days): 1740(follow-up time (months): 57","Homo sapiens",NA,"RNA","Primary Melanoma_029","primary_melanoma_029",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,28,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.7(time to 1st recurrence (days): 127(time to 1st recurrence (months): 4(time to b-met (days): 336(follow-up time (days): 368(follow-up time (months): 12","Homo sapiens",NA,"RNA","Primary Melanoma_030","primary_melanoma_030",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,52,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 6.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1949(follow-up time (months): 64","Homo sapiens",NA,"RNA","Primary Melanoma_031","primary_melanoma_031",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,90,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.48(time to 1st recurrence (days): 741(time to 1st recurrence (months): 25(time to b-met (days): 1209(follow-up time (days): 1351(follow-up time (months): 44","Homo sapiens",NA,"RNA","Primary Melanoma_032","primary_melanoma_032",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,65,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.06(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2266(follow-up time (months): 74","Homo sapiens",NA,"RNA","Primary Melanoma_033","primary_melanoma_033",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,73,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 5(time to 1st recurrence (days): 477(time to 1st recurrence (months): 16(time to b-met (days): NA(follow-up time (days): 1483(follow-up time (months): 48","Homo sapiens",NA,"RNA","Primary Melanoma_034","primary_melanoma_034",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,53,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 8(time to 1st recurrence (days): 1945(time to 1st recurrence (months): 63(time to b-met (days): NA(follow-up time (days): 2546(follow-up time (months): 83","Homo sapiens",NA,"RNA","Primary Melanoma_035","primary_melanoma_035",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,30,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.87(time to 1st recurrence (days): 357(time to 1st recurrence (months): 12(time to b-met (days): NA(follow-up time (days): 363(follow-up time (months): 11","Homo sapiens",NA,"RNA","Primary Melanoma_036","primary_melanoma_036",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,62,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.12(time to 1st recurrence (days): 2006(time to 1st recurrence (months): 66(time to b-met (days): 2006(follow-up time (days): 2155(follow-up time (months): 70","Homo sapiens",NA,"RNA","Primary Melanoma_037","primary_melanoma_037",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,54,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.49(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 791(follow-up time (months): 25","Homo sapiens",NA,"RNA","Primary Melanoma_038","primary_melanoma_038",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,88,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4(time to 1st recurrence (days): 553(time to 1st recurrence (months): 19(time to b-met (days): NA(follow-up time (days): 1695(follow-up time (months): 55","Homo sapiens",NA,"RNA","Primary Melanoma_039","primary_melanoma_039",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,65,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 12(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2322(follow-up time (months): 76","Homo sapiens",NA,"RNA","Primary Melanoma_040","primary_melanoma_040",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,51,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 7(time to 1st recurrence (days): 886(time to 1st recurrence (months): 29(time to b-met (days): NA(follow-up time (days): 2486(follow-up time (months): 81","Homo sapiens",NA,"RNA","Primary Melanoma_041","primary_melanoma_041",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,72,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.6(time to 1st recurrence (days): 620(time to 1st recurrence (months): 20(time to b-met (days): 826(follow-up time (days): 920(follow-up time (months): 30","Homo sapiens",NA,"RNA","Primary Melanoma_042","primary_melanoma_042",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,53,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.9(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2296(follow-up time (months): 75","Homo sapiens",NA,"RNA","Primary Melanoma_043","primary_melanoma_043",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,54,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.5(time to 1st recurrence (days): 1348(time to 1st recurrence (months): 45(time to b-met (days): NA(follow-up time (days): 2200(follow-up time (months): 72","Homo sapiens",NA,"RNA","Primary Melanoma_044","primary_melanoma_044",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,40,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.7(time to 1st recurrence (days): 408(time to 1st recurrence (months): 13(time to b-met (days): NA(follow-up time (days): 757(follow-up time (months): 24","Homo sapiens",NA,"RNA","Primary Melanoma_045","primary_melanoma_045",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,91,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.25(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1461(follow-up time (months): 48","Homo sapiens",NA,"RNA","Primary Melanoma_046","primary_melanoma_046",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,60,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.6(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1363(follow-up time (months): 44","Homo sapiens",NA,"RNA","Primary Melanoma_047","primary_melanoma_047",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,69,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3(time to 1st recurrence (days): 479(time to 1st recurrence (months): 16(time to b-met (days): NA(follow-up time (days): 984(follow-up time (months): 32","Homo sapiens",NA,"RNA","Primary Melanoma_048","primary_melanoma_048",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,64,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 6(time to 1st recurrence (days): 302(time to 1st recurrence (months): 10(time to b-met (days): NA(follow-up time (days): 471(follow-up time (months): 15","Homo sapiens",NA,"RNA","Primary Melanoma_049","primary_melanoma_049",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,89,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1520(follow-up time (months): 49","Homo sapiens",NA,"RNA","Primary Melanoma_050","primary_melanoma_050",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,69,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 8(time to 1st recurrence (days): 454(time to 1st recurrence (months): 15(time to b-met (days): NA(follow-up time (days): 728(follow-up time (months): 23","Homo sapiens",NA,"RNA","Primary Melanoma_051","primary_melanoma_051",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,42,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.8(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1597(follow-up time (months): 52","Homo sapiens",NA,"RNA","Primary Melanoma_052","primary_melanoma_052",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,80,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2(time to 1st recurrence (days): 222(time to 1st recurrence (months): 8(time to b-met (days): 476(follow-up time (days): 667(follow-up time (months): 21","Homo sapiens",NA,"RNA","Primary Melanoma_053","primary_melanoma_053",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,58,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 0.85(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1995(follow-up time (months): 65","Homo sapiens",NA,"RNA","Primary Melanoma_054","primary_melanoma_054",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,67,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.85(time to 1st recurrence (days): 1841(time to 1st recurrence (months): 60(time to b-met (days): 2433(follow-up time (days): 2463(follow-up time (months): 80","Homo sapiens",NA,"RNA","Primary Melanoma_055","primary_melanoma_055",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,56,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 5(time to 1st recurrence (days): 259(time to 1st recurrence (months): 8(time to b-met (days): NA(follow-up time (days): 585(follow-up time (months): 19","Homo sapiens",NA,"RNA","Primary Melanoma_056","primary_melanoma_056",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,50,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.5(time to 1st recurrence (days): 912(time to 1st recurrence (months): 30(time to b-met (days): 1006(follow-up time (days): 1163(follow-up time (months): 38","Homo sapiens",NA,"RNA","Primary Melanoma_057","primary_melanoma_057",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,52,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.2(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1756(follow-up time (months): 57","Homo sapiens",NA,"RNA","Primary Melanoma_058","primary_melanoma_058",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,78,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.4(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2108(follow-up time (months): 69","Homo sapiens",NA,"RNA","Primary Melanoma_059","primary_melanoma_059",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,56,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.1(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1026(follow-up time (months): 33","Homo sapiens",NA,"RNA","Primary Melanoma_060","primary_melanoma_060",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,76,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4(time to 1st recurrence (days): 181(time to 1st recurrence (months): 6(time to b-met (days): 726(follow-up time (days): 873(follow-up time (months): 28","Homo sapiens",NA,"RNA","Primary Melanoma_061","primary_melanoma_061",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,65,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4(time to 1st recurrence (days): 892(time to 1st recurrence (months): 29(time to b-met (days): 1393(follow-up time (days): 1507(follow-up time (months): 49","Homo sapiens",NA,"RNA","Primary Melanoma_062","primary_melanoma_062",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,74,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1850(follow-up time (months): 60","Homo sapiens",NA,"RNA","Primary Melanoma_063","primary_melanoma_063",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,71,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.13(time to 1st recurrence (days): 455(time to 1st recurrence (months): 15(time to b-met (days): NA(follow-up time (days): 1763(follow-up time (months): 57","Homo sapiens",NA,"RNA","Primary Melanoma_064","primary_melanoma_064",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,78,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.8(time to 1st recurrence (days): 358(time to 1st recurrence (months): 11(time to b-met (days): 762(follow-up time (days): 1259(follow-up time (months): 41","Homo sapiens",NA,"RNA","Primary Melanoma_065","primary_melanoma_065",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,53,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1090(follow-up time (months): 35","Homo sapiens",NA,"RNA","Primary Melanoma_066","primary_melanoma_066",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,30,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.85(time to 1st recurrence (days): 430(time to 1st recurrence (months): 14(time to b-met (days): NA(follow-up time (days): 1133(follow-up time (months): 37","Homo sapiens",NA,"RNA","Primary Melanoma_067","primary_melanoma_067",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,56,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.5(time to 1st recurrence (days): 710(time to 1st recurrence (months): 23(time to b-met (days): 726(follow-up time (days): 889(follow-up time (months): 29","Homo sapiens",NA,"RNA","Primary Melanoma_068","primary_melanoma_068",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,72,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.8(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 868(follow-up time (months): 28","Homo sapiens",NA,"RNA","Primary Melanoma_069","primary_melanoma_069",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,39,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1254(follow-up time (months): 41","Homo sapiens",NA,"RNA","Primary Melanoma_070","primary_melanoma_070",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,88,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1492(follow-up time (months): 49","Homo sapiens",NA,"RNA","Primary Melanoma_071","primary_melanoma_071",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,81,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 0.85(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1415(follow-up time (months): 46","Homo sapiens",NA,"RNA","Primary Melanoma_072","primary_melanoma_072",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,65,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.88(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1023(follow-up time (months): 33","Homo sapiens",NA,"RNA","Primary Melanoma_073","primary_melanoma_073",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,37,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.25(time to 1st recurrence (days): 1283(time to 1st recurrence (months): 42(time to b-met (days): NA(follow-up time (days): 1315(follow-up time (months): 43","Homo sapiens",NA,"RNA","Primary Melanoma_074","primary_melanoma_074",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,64,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 5.5(time to 1st recurrence (days): 561(time to 1st recurrence (months): 18(time to b-met (days): NA(follow-up time (days): 862(follow-up time (months): 28","Homo sapiens",NA,"RNA","Primary Melanoma_075","primary_melanoma_075",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,78,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 0.52(time to 1st recurrence (days): 2302(time to 1st recurrence (months): 75(time to b-met (days): 2319(follow-up time (days): 2817(follow-up time (months): 92","Homo sapiens",NA,"RNA","Primary Melanoma_076","primary_melanoma_076",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,66,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1668(follow-up time (months): 54","Homo sapiens",NA,"RNA","Primary Melanoma_077","primary_melanoma_077",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,78,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.2(time to 1st recurrence (days): 177(time to 1st recurrence (months): 6(time to b-met (days): NA(follow-up time (days): 345(follow-up time (months): 11","Homo sapiens",NA,"RNA","Primary Melanoma_078","primary_melanoma_078",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,61,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1708(follow-up time (months): 56","Homo sapiens",NA,"RNA","Primary Melanoma_079","primary_melanoma_079",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,56,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 10(time to 1st recurrence (days): 1086(time to 1st recurrence (months): 36(time to b-met (days): NA(follow-up time (days): 2703(follow-up time (months): 88","Homo sapiens",NA,"RNA","Primary Melanoma_080","primary_melanoma_080",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,50,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.05(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 596(follow-up time (months): 19","Homo sapiens",NA,"RNA","Primary Melanoma_081","primary_melanoma_081",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,86,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 8(time to 1st recurrence (days): 629(time to 1st recurrence (months): 20(time to b-met (days): NA(follow-up time (days): 778(follow-up time (months): 25","Homo sapiens",NA,"RNA","Primary Melanoma_082","primary_melanoma_082",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,81,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 904(follow-up time (months): 29","Homo sapiens",NA,"RNA","Primary Melanoma_083","primary_melanoma_083",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,65,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.2(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 838(follow-up time (months): 27","Homo sapiens",NA,"RNA","Primary Melanoma_084","primary_melanoma_084",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,86,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 0.89(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 836(follow-up time (months): 27","Homo sapiens",NA,"RNA","Primary Melanoma_085","primary_melanoma_085",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,20,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.25(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1518(follow-up time (months): 49","Homo sapiens",NA,"RNA","Primary Melanoma_086","primary_melanoma_086",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,44,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3(time to 1st recurrence (days): 455(time to 1st recurrence (months): 15(time to b-met (days): NA(follow-up time (days): 1580(follow-up time (months): 51","Homo sapiens",NA,"RNA","Primary Melanoma_087","primary_melanoma_087",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,82,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.24(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1575(follow-up time (months): 51","Homo sapiens",NA,"RNA","Primary Melanoma_088","primary_melanoma_088",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,70,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 13(time to 1st recurrence (days): 1189(time to 1st recurrence (months): 39(time to b-met (days): 1659(follow-up time (days): 1733(follow-up time (months): 57","Homo sapiens",NA,"RNA","Primary Melanoma_089","primary_melanoma_089",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,28,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3(time to 1st recurrence (days): 1530(time to 1st recurrence (months): 50(time to b-met (days): 1673(follow-up time (days): 2041(follow-up time (months): 67","Homo sapiens",NA,"RNA","Primary Melanoma_090","primary_melanoma_090",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,48,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.37(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1172(follow-up time (months): 38","Homo sapiens",NA,"RNA","Primary Melanoma_091","primary_melanoma_091",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,63,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.15(time to 1st recurrence (days): 469(time to 1st recurrence (months): 15(time to b-met (days): NA(follow-up time (days): 1519(follow-up time (months): 49","Homo sapiens",NA,"RNA","Primary Melanoma_092","primary_melanoma_092",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,66,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 8.5(time to 1st recurrence (days): 83(time to 1st recurrence (months): 2(time to b-met (days): NA(follow-up time (days): 226(follow-up time (months): 7","Homo sapiens",NA,"RNA","Primary Melanoma_093","primary_melanoma_093",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,40,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4(time to 1st recurrence (days): 553(time to 1st recurrence (months): 19(time to b-met (days): NA(follow-up time (days): 1497(follow-up time (months): 49","Homo sapiens",NA,"RNA","Primary Melanoma_094","primary_melanoma_094",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,58,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.37(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 720(follow-up time (months): 23","Homo sapiens",NA,"RNA","Primary Melanoma_095","primary_melanoma_095",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,50,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 7(time to 1st recurrence (days): 3(time to 1st recurrence (months): 0(time to b-met (days): 3(follow-up time (days): 567(follow-up time (months): 18","Homo sapiens",NA,"RNA","Primary Melanoma_096","primary_melanoma_096",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,56,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.55(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1486(follow-up time (months): 48","Homo sapiens",NA,"RNA","Primary Melanoma_097","primary_melanoma_097",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,42,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1358(follow-up time (months): 44","Homo sapiens",NA,"RNA","Primary Melanoma_098","primary_melanoma_098",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,49,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4(time to 1st recurrence (days): 901(time to 1st recurrence (months): 29(time to b-met (days): 1240(follow-up time (days): 1252(follow-up time (months): 41","Homo sapiens",NA,"RNA","Primary Melanoma_099","primary_melanoma_099",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,81,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.3(time to 1st recurrence (days): 588(time to 1st recurrence (months): 20(time to b-met (days): 588(follow-up time (days): 1407(follow-up time (months): 46","Homo sapiens",NA,"RNA","Primary Melanoma_100","primary_melanoma_100",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,65,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.2(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 848(follow-up time (months): 27","Homo sapiens",NA,"RNA","Primary Melanoma_101","primary_melanoma_101",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,72,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.95(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1326(follow-up time (months): 43","Homo sapiens",NA,"RNA","Primary Melanoma_102","primary_melanoma_102",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,78,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.36(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1395(follow-up time (months): 45","Homo sapiens",NA,"RNA","Primary Melanoma_103","primary_melanoma_103",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,62,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.9(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 678(follow-up time (months): 22","Homo sapiens",NA,"RNA","Primary Melanoma_104","primary_melanoma_104",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,82,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2.5(time to 1st recurrence (days): 1200(time to 1st recurrence (months): 39(time to b-met (days): NA(follow-up time (days): 1295(follow-up time (months): 42","Homo sapiens",NA,"RNA","Primary Melanoma_105","primary_melanoma_105",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,54,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2(time to 1st recurrence (days): 233(time to 1st recurrence (months): 8(time to b-met (days): 957(follow-up time (days): 1201(follow-up time (months): 39","Homo sapiens",NA,"RNA","Primary Melanoma_106","primary_melanoma_106",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,53,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 11(time to 1st recurrence (days): 148(time to 1st recurrence (months): 5(time to b-met (days): 148(follow-up time (days): 242(follow-up time (months): 7","Homo sapiens",NA,"RNA","Primary Melanoma_107","primary_melanoma_107",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,79,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4(time to 1st recurrence (days): 207(time to 1st recurrence (months): 7(time to b-met (days): NA(follow-up time (days): 374(follow-up time (months): 12","Homo sapiens",NA,"RNA","Primary Melanoma_108","primary_melanoma_108",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,91,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.2(time to 1st recurrence (days): 561(time to 1st recurrence (months): 18(time to b-met (days): NA(follow-up time (days): 1676(follow-up time (months): 55","Homo sapiens",NA,"RNA","Primary Melanoma_109","primary_melanoma_109",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,79,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 9.6(time to 1st recurrence (days): 49(time to 1st recurrence (months): 1(time to b-met (days): 152(follow-up time (days): 165(follow-up time (months): 5","Homo sapiens",NA,"RNA","Primary Melanoma_110","primary_melanoma_110",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,34,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 12(time to 1st recurrence (days): 273(time to 1st recurrence (months): 9(time to b-met (days): NA(follow-up time (days): 1570(follow-up time (months): 51","Homo sapiens",NA,"RNA","Primary Melanoma_111","primary_melanoma_111",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,62,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.62(time to 1st recurrence (days): 3965(time to 1st recurrence (months): 130(time to b-met (days): NA(follow-up time (days): 4924(follow-up time (months): 161","Homo sapiens",NA,"RNA","Primary Melanoma_112","primary_melanoma_112",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,51,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 2(time to 1st recurrence (days): 1226(time to 1st recurrence (months): 41(time to b-met (days): NA(follow-up time (days): 1623(follow-up time (months): 53","Homo sapiens",NA,"RNA","Primary Melanoma_113","primary_melanoma_113",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,44,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 4.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1469(follow-up time (months): 48","Homo sapiens",NA,"RNA","Primary Melanoma_114","primary_melanoma_114",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,30,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 7(time to 1st recurrence (days): 364(time to 1st recurrence (months): 12(time to b-met (days): 544(follow-up time (days): 592(follow-up time (months): 19","Homo sapiens",NA,"RNA","Primary Melanoma_115","primary_melanoma_115",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,72,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.7(time to 1st recurrence (days): 455(time to 1st recurrence (months): 15(time to b-met (days): 455(follow-up time (days): 620(follow-up time (months): 20","Homo sapiens",NA,"RNA","Primary Melanoma_116","primary_melanoma_116",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,76,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 1.3(time to 1st recurrence (days): 352(time to 1st recurrence (months): 12(time to b-met (days): 433(follow-up time (days): 484(follow-up time (months): 15","Homo sapiens",NA,"RNA","Primary Melanoma_117","primary_melanoma_117",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,57,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3(time to 1st recurrence (days): 1879(time to 1st recurrence (months): 61(time to b-met (days): NA(follow-up time (days): 2126(follow-up time (months): 69","Homo sapiens",NA,"RNA","Primary Melanoma_118","primary_melanoma_118",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,72,NA,NA,NA,NA,NA,NA,NA,NA
"total RNA","total RNA","Cutaneous primary melanoma","Public on Feb 01 2015",NA,NA,NA,NA,NA,"Common Reference",NA,"material: Equal mixture of all samples",NA,NA,"GSE62371, GSE62372",NA,"1_Exiqon is Cy3","primary tumor thickness (mm): 3.75(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2870(follow-up time (months): 94","Homo sapiens",NA,"RNA","Primary Melanoma_119","primary_melanoma_119",NA,"Cy5 (Hy5)",NA,NA,NA,NA,NA,NA,NA,NA,47,NA,NA,NA,NA,NA,NA,NA,NA
